Baidu
map

消化

订阅

MedSci主页 / 所有栏目 / 消化

SM-88治疗晚期胰腺癌患者的TYME-88-Panc II期研究：整体生存趋势获益

2019-07-07 Allan MedSci原创

SM-88晚期胰腺癌代谢
关注

Tyme是一家基于癌症代谢疗法的生物技术公司，近日宣布，评估SM-88（外消旋酪氨酸）单药治疗晚期胰腺癌患者的II期TYME-88-Panc研究表现出令人鼓舞的有效性和安全性。

Tyme是一家基于癌症代谢疗法的生物技术公司，近日宣布，评估SM-88（外消旋酪氨酸）单药治疗晚期胰腺癌患者的II期TYME-88-Panc研究表现出令人鼓舞的有效性和安全性。来自TYME-88-Pan   c研究的数据已于2019年7月4日在西班牙巴塞罗那举行第21届ESMO世界胃肠癌大会上发表。

结果显示，截至2019年4月25日，SM-88治疗的晚期胰腺癌患者的中位总生存期（OS）为6.4个月；功效指标显示，SM-88的治疗与更高的总生存期（OS）、稳定疾病（SD）、减少循环肿瘤细胞（CTC）密切相关；SM-88将死亡风险降低了92％。


原始出处：

http://www.firstwordpharma.com/node/1651581#axzz5syvQI0kQ

本文系梅斯医学（MedSci）原创编译整理，转载需授权!

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665198, encodeId=b30816651981e, content=<a href='/topic/show?id=29aa16422e9' target=_blank style='color:#2F92EE;'>#SM-88#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16422, encryptionId=29aa16422e9, topicName=SM-88)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca5925907743, createdName=446798725_87912773, createdTime=Wed Jan 15 20:56:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389571, encodeId=d93113895e114, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59881, encryptionId=82a95988106, topicName=晚期胰腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jul 09 09:56:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369255, encodeId=9482369255cf, content=好的研究，值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sun Jul 07 22:18:34 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369248, encodeId=b51a36924820, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 07 19:32:24 CST 2019, time=2019-07-07, status=1, ipAttribution=)]
    2020-01-15 446798725_87912773

    #SM-88#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1665198, encodeId=b30816651981e, content=<a href='/topic/show?id=29aa16422e9' target=_blank style='color:#2F92EE;'>#SM-88#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16422, encryptionId=29aa16422e9, topicName=SM-88)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca5925907743, createdName=446798725_87912773, createdTime=Wed Jan 15 20:56:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389571, encodeId=d93113895e114, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59881, encryptionId=82a95988106, topicName=晚期胰腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jul 09 09:56:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369255, encodeId=9482369255cf, content=好的研究，值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sun Jul 07 22:18:34 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369248, encodeId=b51a36924820, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 07 19:32:24 CST 2019, time=2019-07-07, status=1, ipAttribution=)]
    2019-07-09 ms7899726347904398

    #晚期胰腺癌#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1665198, encodeId=b30816651981e, content=<a href='/topic/show?id=29aa16422e9' target=_blank style='color:#2F92EE;'>#SM-88#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16422, encryptionId=29aa16422e9, topicName=SM-88)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca5925907743, createdName=446798725_87912773, createdTime=Wed Jan 15 20:56:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389571, encodeId=d93113895e114, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59881, encryptionId=82a95988106, topicName=晚期胰腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jul 09 09:56:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369255, encodeId=9482369255cf, content=好的研究，值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sun Jul 07 22:18:34 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369248, encodeId=b51a36924820, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 07 19:32:24 CST 2019, time=2019-07-07, status=1, ipAttribution=)]
    2019-07-07 njwbhuang

    好的研究，值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1665198, encodeId=b30816651981e, content=<a href='/topic/show?id=29aa16422e9' target=_blank style='color:#2F92EE;'>#SM-88#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16422, encryptionId=29aa16422e9, topicName=SM-88)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca5925907743, createdName=446798725_87912773, createdTime=Wed Jan 15 20:56:00 CST 2020, time=2020-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389571, encodeId=d93113895e114, content=<a href='/topic/show?id=82a95988106' target=_blank style='color:#2F92EE;'>#晚期胰腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59881, encryptionId=82a95988106, topicName=晚期胰腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/1103841572/2898B09F0DA89357D0D54A725E611AC7/100, createdBy=fdd32500040, createdName=ms7899726347904398, createdTime=Tue Jul 09 09:56:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369255, encodeId=9482369255cf, content=好的研究，值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43a21971117, createdName=njwbhuang, createdTime=Sun Jul 07 22:18:34 CST 2019, time=2019-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=369248, encodeId=b51a36924820, content=学习了，谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun Jul 07 19:32:24 CST 2019, time=2019-07-07, status=1, ipAttribution=)]
    2019-07-07 1ddf0692m34(暂无匿称)

    学习了，谢谢分享

    0

相关资讯

Tyme获得FDA关于SM-88治疗晚期胰腺癌的指导


Tyme是一家新兴的生物技术公司，开发基于代谢的癌症疗法，宣布它获得了美国食品和药品监督管理局（FDA）关于SM-88注册试验的设计指导。这项招募了88名晚期胰腺癌患者的临床试验旨在获得试验终点和满足FDA的监管要求。

Baidu
map
Baidu
map
Baidu
map